Rate My Professor Richard Stanton

Stanton's research specializations encompass the biology, immunology, and diagnosis of human cytomegalovirus (HCMV), alongside the development of recombinant adenovirus vectors. He contributes to the Viral Immunology Research Group and Cytomegalovirus and Adenovirus Virology group. Notable publications include 'Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity' (Proceedings of the National Academy of Sciences, 2025), 'HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation' (Proceedings of the National Academy of Sciences, 2023), 'Reconstruction of the complete human cytomegalovirus genome' (2010), and 'HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells' (Cell Host and Microbe, 2014). Stanton holds editorial roles as Editor for PNAS Nexus, PLoS Pathogens, and Scientific Reports, and Editorial Board Member for the Journal of General Virology. He serves on the Wellcome Trust Discovery Award Advisory Group, Healthcare Research Wales Fellowship Grant committee, and other panels. Professional memberships include the Microbiology Society, American Society for Microbiology, and British Society for Immunology.